Boston Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,298,879
Closed -$24.3M 752
2023
Q2
$24.3M Sell
1,298,879
-1,713,956
-57% -$27.2M 0.03% 292
2023
Q1
$53.3M Sell
3,012,835
-42,219
-1% -$705K 0.07% 225
2022
Q4
$29.5M Sell
3,055,054
-54,289
-2% -$405K 0.04% 260
2022
Q3
$21M Buy
3,109,343
+2,203,400
+243% +$36.6M 0.03% 287
2022
Q2
$17.7M Buy
905,943
+7,490
+0.8% +$157K 0.02% 325
2022
Q1
$19.5M Sell
898,453
-32,482
-3% -$689K 0.02% 323
2021
Q4
$21.9M Sell
930,935
-27,961
-3% -$669K 0.03% 315
2021
Q3
$25.1M Buy
958,896
+231,540
+32% +$5.6M 0.03% 309
2021
Q2
$17.6M Buy
727,356
+140,478
+24% +$3.46M 0.02% 335
2021
Q1
$14.6M Buy
586,878
+209,199
+55% +$5.53M 0.02% 345
2020
Q4
$10.4M Buy
+377,679
New +$10.1M 0.02% 339

Other funds holding SHC

Boston Partners's SHC Position: Q3 2023 in Review

Boston Partners sold out of Sotera Health (SHC) in Q3 2023, closing a stake of 1,298,879 shares — an estimated $24.3M sold.

Boston Partners first reported a position in SHC in Q4 2020 and held it in 11 quarters. The position peaked at $53.3M in Q1 2023. 169 funds tracked by Wall St. Rank hold SHC as of Q3 2023.

  • Boston Partners reported no remaining Sotera Health position as of Q3 2023 after selling out during the quarter.
  • Boston Partners sold 1,298,879 Sotera Health shares in Q3 2023, an estimated $24.3M.
  • Boston Partners first reported a position in Sotera Health in Q4 2020 and held it in 11 quarters.
  • Boston Partners's Sotera Health position peaked at $53.3M in Q1 2023.
  • 169 funds tracked by Wall St. Rank held Sotera Health as of Q3 2023.

Based on Boston Partners's 13F filing for Q3 2023, filed 8 Nov 2023.